$ETBI: NEXT BIG OTC BIOTECH RUNNER 52 WEEK HIGH
Post# of 103076
(Total Views: 2933)
Posted On: 03/06/2018 10:01:01 PM
$ETBI: NEXT BIG OTC BIOTECH RUNNER
52 WEEK HIGH=.045, CURRENTLY ONLY .0042 HUGE UPSIDE!
NON-DILUTIVE FINANCING, CLEAN LEVEL II
$ETBI IS LOOKING LIKE A GREAT TURNAROUND STORY DEVELOPING.
RECENT NEWS
EastGate Biotech Announces Licensing/Distribution MOU With BuPharco for the Insulin Mouth Rinse in the Philippines for Type 2 Diabetes Patients
ACCESSWIRE | 03/05/2018
Eastgate Biotech Provides Corporate Update
ACCESSWIRE | 03/01/2018
GOOD READS:
Eastgate Biotech Corp. (OTC: ETBI) on the Diabetic Road to Recovery
FUD on Eastgate Biotech Could be Last Stand for Naked Short Position
EastGate Biotech (OTC Pink: ETBI) Finds Non-Dilutive Sweet Spot in Philippines
Eastgate Biotech Corp Website
52 WEEK HIGH=.045, CURRENTLY ONLY .0042 HUGE UPSIDE!
NON-DILUTIVE FINANCING, CLEAN LEVEL II
$ETBI IS LOOKING LIKE A GREAT TURNAROUND STORY DEVELOPING.
RECENT NEWS
EastGate Biotech Announces Licensing/Distribution MOU With BuPharco for the Insulin Mouth Rinse in the Philippines for Type 2 Diabetes Patients
ACCESSWIRE | 03/05/2018
Eastgate Biotech Provides Corporate Update
ACCESSWIRE | 03/01/2018
GOOD READS:
Eastgate Biotech Corp. (OTC: ETBI) on the Diabetic Road to Recovery
FUD on Eastgate Biotech Could be Last Stand for Naked Short Position
EastGate Biotech (OTC Pink: ETBI) Finds Non-Dilutive Sweet Spot in Philippines
Eastgate Biotech Corp Website
(3)
(0)
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.
Scroll down for more posts ▼